These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 8036706

  • 21. Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation.
    Aliabadi AZ, Mahr S, Dunkler D, Grömmer M, Zimpfer D, Wolner E, Grimm M, Zuckermann AO.
    Transplantation; 2008 Dec 27; 86(12):1771-6. PubMed ID: 19104420
    [Abstract] [Full Text] [Related]

  • 22. [Effects of simvastatin on blood levels of lipoprotein (a)].
    Galetta F, Sampietro T, Basta G, Giannasi G, Bionda A.
    Minerva Med; 1995 Dec 27; 86(7-8):299-303. PubMed ID: 7478073
    [Abstract] [Full Text] [Related]

  • 23. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
    Fernández-Miranda C, de la Calle A, Morales JM, Guijarro C, Aranda JL, Gómez-Sanz R, Gómez-Izquierdo T, Larumbe S, Moreno E, Rodicio JL, del Palacio A.
    Clin Transplant; 1998 Apr 27; 12(2):136-41. PubMed ID: 9575402
    [Abstract] [Full Text] [Related]

  • 24. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec 27; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 25. Effect of simvastatin in CAPD patients with hypercholesterolemia.
    De Vecchi A, Scalamogna A, Paparella M, Colombini M, Rovellini A, Pini C, Castelnovo C.
    Adv Perit Dial; 1992 Dec 27; 8():331-3. PubMed ID: 1361817
    [Abstract] [Full Text] [Related]

  • 26. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 27; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 27. [Multicenter comparative study on safety, tolerance, and effectiveness of lovastatin combined or not with cholestyramine, and gemfibrozil combined or not with cholestyramine in the treatment of primary hypercholesterolemia].
    Jover E, Aranda JL, Nogués X, del Palacio A, Rubiés-Prat J.
    Med Clin (Barc); 1996 May 25; 106(20):776-9. PubMed ID: 8801396
    [Abstract] [Full Text] [Related]

  • 28. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 May 25; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 29. [The effects of the cholesterol synthesis inhibitor simvastatin in patients with hypercholesterolemia with and without diabetes mellitus].
    van Deursen RT, Nieuwenhuijzen Kruseman AC, Degenaar CP, Wolffenbuttel BH.
    Ned Tijdschr Geneeskd; 1990 Nov 03; 134(44):2142-6. PubMed ID: 2247172
    [Abstract] [Full Text] [Related]

  • 30. [Effectiveness and tolerability of simvastatin in subjects with primary hypercholesterolemia. Multicenter study].
    Finardi G, Perani G, Tramarin R, Ricciardi R, Falaschi F, Franco C.
    Clin Ter; 1993 Mar 03; 142(3):225-33. PubMed ID: 8482062
    [Abstract] [Full Text] [Related]

  • 31. The impact of steroid withdrawal on the development of lipid abnormalities and obesity in heart transplant recipients.
    Lake KD, Reutzel TJ, Pritzker MR, Jorgensen CR, Emery RW.
    J Heart Lung Transplant; 1993 Mar 03; 12(4):580-90. PubMed ID: 8369320
    [Abstract] [Full Text] [Related]

  • 32. [A comparison of bezafibrate and lovastatin treatment at the usual doses in post-heart transplant hyperlipemia].
    Zambrana García JL, López Miranda J, Anguita Sánchez M, Blanco Cerrada J, Vallés Belsúe F, Casares Mediavilla J, Muñoz Carvajal I, Jiménez Perepérez JA, Pérez Jiménez F.
    Rev Esp Cardiol; 1996 Dec 03; 49(12):892-8. PubMed ID: 9026840
    [Abstract] [Full Text] [Related]

  • 33. Low-dose simvastatin is safe in hyperlipidaemic renal transplant patients.
    Martinez Hernandez BE, Persaud JW, Varghese Z, Moorhead JF.
    Nephrol Dial Transplant; 1993 Dec 03; 8(7):637-41. PubMed ID: 8396749
    [Abstract] [Full Text] [Related]

  • 34. [Effectiveness and tolerability of simvastatin in patients with moderate-to-severe hypercholesterolemia. Results of a 12-month study].
    Ghizzoni G, Rusconi C, Faggiano P, Sabatini T, Oneglia C, Gardini A.
    Minerva Cardioangiol; 1993 Mar 03; 41(3):105-9. PubMed ID: 8510811
    [Abstract] [Full Text] [Related]

  • 35. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study.
    Pedersen TR, Berg K, Cook TJ, Faergeman O, Haghfelt T, Kjekshus J, Miettinen T, Musliner TA, Olsson AG, Pyörälä K, Thorgeirsson G, Tobert JA, Wedel H, Wilhelmsen L.
    Arch Intern Med; 1996 Oct 14; 156(18):2085-92. PubMed ID: 8862101
    [Abstract] [Full Text] [Related]

  • 36. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
    Seipelt IM, Crawford SE, Rodgers S, Backer C, Mavroudis C, Seipelt RG, Pahl E.
    J Heart Lung Transplant; 2004 Mar 14; 23(3):317-22. PubMed ID: 15019641
    [Abstract] [Full Text] [Related]

  • 37. Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus.
    Trotter JF, Wachs ME, Trouillot TE, Bak T, Kugelmas M, Kam I, Everson G.
    Liver Transpl; 2001 May 14; 7(5):401-8. PubMed ID: 11349259
    [Abstract] [Full Text] [Related]

  • 38. Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS study).
    Garmendia F, Brown AS, Reiber I, Adams PC.
    Curr Med Res Opin; 2000 May 14; 16(3):208-19. PubMed ID: 11191012
    [Abstract] [Full Text] [Related]

  • 39. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion.
    White M, Haddad H, Leblanc MH, Giannetti N, Pflugfelder P, Davies R, Isaac D, Burton J, Chan M, Azevedo E, Howlett J, Ignaszewski A, Busque S, Cantarovich M, Ferguson R, Genest J, Ross H.
    J Heart Lung Transplant; 2005 Jul 14; 24(7):798-809. PubMed ID: 15982605
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of rosuvastatin therapy for the prevention of hyperlipidemia in adult cardiac transplant recipients.
    Samman A, Imai C, Straatman L, Frolich J, Humphries K, Ignaszewski A.
    J Heart Lung Transplant; 2005 Aug 14; 24(8):1008-13. PubMed ID: 16102434
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.